Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Insulin-like growth factor binding protein-6 (IGFBP-6) interacts with DNA-end binding protein Ku80 to regulate cell fate

Iosef C, Vilk G, Gkourasas T, Lee KJ, Chen BP, Fu P, Bach LA, Lajoie G, Gupta MB, Li SS, Han VK

(2010), Cell Signal, 22(7), 1033-43

Diagnostic characteristics of clozapine-induced myocarditis identified by an analysis of 38 cases and 47 controls

Ronaldson KJ, Taylor AJ, Fitzgerald PB, Topliss DJ, Elsik M, McNeil JJ

(2010), J Clin Psychiatry, 71(8), 976-81

The 4-mg intravenous dexamethasone suppression test in the diagnosis of Cushing's syndrome

Jung C, Alford FP, Topliss DJ, Burgess JR, Long F, Gome JJ, Stockigt JR, Inder WJ

(2010), Clin Endocrinol, 73(1), 78-84

Glycated proteins bind to ERM proteins and modulate their actions

Bach LA, Young A, Gallicchio MA, McRobert EA

(2010), In: Thomas MC, Forbes J (eds), Maillard Reaction: Interface between Aging, Nutrition and Metabolism, Royal Society of Chemistry, Cambridge, UK, 31-7

Cushing syndrome in a young woman due to primary pigmented nodular adrenal disease

Hackman KL, Davis AL, Curnow PA, Serpell JW, McLean CA, Topliss DJ

(2010), Endocr Pract, 16(1), 84-8

Recombinant human thyroid-stimulating hormone (Thyrogen) in thyroid cancer follow up: experience at a single institution

Wong R, Topliss DJ, Bach LA, Hamblin PS, Kalff V, Long F, Stockigt JR

(2009), Intern Med J, 39(3), 156-63

Medications that distort in vitro tests of thyroid function, with particular reference to estimates of serum free thyroxine

Stockigt JR, Lim CF

(2009), Best Pract Res Clin Endocrinol Metab, 23(6), 753-67

Intravenous zoledronate improves bone density in adults with cystic fibrosis (CF)

Chapman I, Greville H, Ebeling PR, King SJ, Kotsimbos T, Nugent P, Player R, Topliss DJ, Warner J, Wilson JW

(2009), Clin Endocrinol, 70(6), 838-46

Diabetes and cystic fibrosis

Topliss DJ

(2008), Diabetes Manag J, 25, 10

Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention)

Origin Trial Investigators, Gerstein H, Yusuf S, Riddle MC, Ryden L, Bosch J

(2008), Am Heart J, 155(1), 26-32, 32.e1-6

Association of a nicotinic receptor mutation with reduced height and blunted physostigmine-stimulated growth hormone release

Fedi M, Bach LA, Berkovic SF, Willoughby JO, Scheffer IE, Reutens DC

(2008), J Clin Endocrinol Metab, 93(2), 634-7

Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial

DREAM Trial Investigators, Dagenais GR, Gerstein HC, Holman R, Budaj A, Escalante A, Hedner T, Keltai M, Lonn E, McFarlane S, McQueen M, Teo K, Sheridan P, Bosch J, Pogue J, Yusuf S

(2008), Diabetes Care, 31(5), 1007-14

Outcomes for general medical inpatients with diabetes mellitus and new hyperglycaemia

Baker ST, Chiang CY, Zajac JD, Bach LA, Jerums G, MacIsaac RJ

(2008), Med J Aust, 188(6), 340-3

Rho kinase inhibition: a new approach for treating diabetic nephropathy?

Bach LA

(2008), Diabetes, 57(3), 532-3

Post-transplant diabetes

Bach LA

(2008), Diabetes Manag J, 25, 8-9

Blogging during terminal care: communication, color schemes, and creating a community

Bach LA

(2008), J Clin Oncol, 26(27), 4504-6

Metastatic colorectal cancer to a primary thyroid cancer.

Cherk MH, Moore M, Serpell J, Swain S, Topliss DJ

(2008), World J Surg Oncol, 6, 122

Incidence of radiation thyroiditis and thyroid remnant ablation success rates following 1110 MBq (30 mCi) and 3700 MBq (100 mCi) post-surgical 131I ablation therapy for differentiated thyroid carcinoma

Cherk MH, Kalff V, Yap KS, Bailey M, Topliss D, Kelly MJ

(2008), Clin Endocrinol, 69(6), 957-62

Gonadotroph adenoma in multiple endocrine neoplasia type 1

Sztal-Mazer S, Topliss DJ, Simpson RW, Hamblin PS, Rosenfeld JV, McLean CA

(2008), Endocr Pract, 14(5), 592-4

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

Patel A; ADVANCE Collaborative Group, MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, Harrap S, Poulter N, Marre M, Cooper M, Glasziou P, Grobbee DE, Hamet P, Heller S, Liu LS, Mancia G, Mogensen CE, Pan CY, Rodgers A, Williams B

(2007), Lancet, 370(9590), 829-40

5 6 7 8